Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Verny

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Cerebrovascular Diseases (Basel, Switzerland)|March 12, 2005
Isolated Horner's syndrome may herald strokeJean-Michel de Bray, Ralf Baumgartner, Benoit Guillon, et al.
Brain : a Journal of Neurology|February 7, 2013
Sensorineural hearing loss in OPA1-linked disordersStéphanie Leruez, Dan Milea, Sabine Defoort-Dhellemmes, et al.
Neurobiology of Disease|August 28, 2015
OPA1-related disorders: Diversity of clinical expression, modes of inheritance and pathophysiologyJuan Manuel Chao de la Barca, Delphine Prunier-Mirebeau, Patrizia Amati-Bonneau, et al.
Investigative Ophthalmology & Visual Science|January 18, 2018
A Plasma Metabolomic Signature Involving Purine Metabolism in Human Optic Atrophy 1 (OPA1)-Related DisordersCinzia Bocca, Judith Kouassi Nzoughet, Stéphanie Leruez, et al.
Plos One|January 24, 2014
Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohortGaëlle Désaméricq, Guillaume Dolbeau, Christophe Verny, et al.
Investigative Ophthalmology & Visual Science|February 17, 2018
A Plasma Metabolomic Signature of the Exfoliation Syndrome Involves Amino Acids, Acylcarnitines, and PolyaminesStéphanie Leruez, Thomas Bresson, Juan M Chao de la Barca, et al.
Annals of Neurology|October 22, 2005
OPA1 R445H mutation in optic atrophy associated with sensorineural deafnessPatrizia Amati-Bonneau, Agnès Guichet, Aurélien Olichon, et al.
Investigative Ophthalmology & Visual Science|September 8, 2018
A Metabolomics Profiling of Glaucoma Points to Mitochondrial Dysfunction, Senescence, and Polyamines DeficiencyStéphanie Leruez, Alexandre Marill, Thomas Bresson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 25, 2017
A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's diseaseChristophe Verny, Anne-Catherine Bachoud-Lévi, Alexandra Durr, et al.
The Lancet. Neurology|January 22, 2022
Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trialGiulia Coarelli, Anna Heinzmann, Claire Ewenczyk, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Cerebrovascular Diseases (Basel, Switzerland)|March 12, 2005
Isolated Horner's syndrome may herald strokeJean-Michel de Bray, Ralf Baumgartner, Benoit Guillon, et al.
Brain : a Journal of Neurology|February 7, 2013
Sensorineural hearing loss in OPA1-linked disordersStéphanie Leruez, Dan Milea, Sabine Defoort-Dhellemmes, et al.
Neurobiology of Disease|August 28, 2015
OPA1-related disorders: Diversity of clinical expression, modes of inheritance and pathophysiologyJuan Manuel Chao de la Barca, Delphine Prunier-Mirebeau, Patrizia Amati-Bonneau, et al.
Investigative Ophthalmology & Visual Science|January 18, 2018
A Plasma Metabolomic Signature Involving Purine Metabolism in Human Optic Atrophy 1 (OPA1)-Related DisordersCinzia Bocca, Judith Kouassi Nzoughet, Stéphanie Leruez, et al.
Plos One|January 24, 2014
Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohortGaëlle Désaméricq, Guillaume Dolbeau, Christophe Verny, et al.
Investigative Ophthalmology & Visual Science|February 17, 2018
A Plasma Metabolomic Signature of the Exfoliation Syndrome Involves Amino Acids, Acylcarnitines, and PolyaminesStéphanie Leruez, Thomas Bresson, Juan M Chao de la Barca, et al.
Annals of Neurology|October 22, 2005
OPA1 R445H mutation in optic atrophy associated with sensorineural deafnessPatrizia Amati-Bonneau, Agnès Guichet, Aurélien Olichon, et al.
Investigative Ophthalmology & Visual Science|September 8, 2018
A Metabolomics Profiling of Glaucoma Points to Mitochondrial Dysfunction, Senescence, and Polyamines DeficiencyStéphanie Leruez, Alexandre Marill, Thomas Bresson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 25, 2017
A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's diseaseChristophe Verny, Anne-Catherine Bachoud-Lévi, Alexandra Durr, et al.
The Lancet. Neurology|January 22, 2022
Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trialGiulia Coarelli, Anna Heinzmann, Claire Ewenczyk, et al.
Pageof 10